Symeon M.
- Country
- Greece
- Department
- 1st Department of Internal Medicine
Research Overview
- A Randomized, Placebo‑Controlled Trial of Zenagamtide (NNC0487‑0111) in Obese Patients with HFpEF or HFmrEF to Reduce CV Death and HF Hospitalization
- Rifabutin plus polymyxin B combination for adult patients with hospital/ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii
- A Phase 3b Study Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Antiretroviral-Naive Adults with HIV
Data & Insights
Has run more than one trial at 29 of 298 partner sites.
Specializations
Infectious Diseases
The investigator focuses on treating Human Immunodeficiency Virus (HIV), exploring innovative therapeutic approaches through antiretroviral regimens. Their work involves evaluating the effectiveness of simplified treatment protocols for treatment-naïve patients.
- HIV Treatment Optimization
- Antiretroviral Therapy
Research interests extend to developing more streamlined treatment approaches while maintaining therapeutic efficacy.
Critical Infections
Expertise centers on managing severe infections with particular attention to antibiotic stewardship. The investigator explores diagnostic-guided approaches to optimize antimicrobial therapy and improve treatment outcomes.
- Antibiotic Management
- Diagnostic-Guided Therapy
- Infection Control
Focus includes implementing biomarker-based strategies to enhance therapeutic precision.
Respiratory Medicine
The investigator specializes in treating community-acquired pneumonia and post-acute COVID syndrome. Their work encompasses innovative therapeutic approaches using biomarker-guided interventions and targeted immunomodulatory treatments.
- Pneumonia Management
- COVID-19 Complications
- Respiratory Therapeutics
Research concentrates on preventing disease progression and managing long-term respiratory complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.